S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e252478c-n/a
Main Authors: Russell, Nigel, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm‐Benartzi, Charlotte, Knapper, Steven, Batten, Leona, Canham, Joanna, Hinson, Emily Laura, Malthe Overgaard, Ulrik, Gilkes, Amanda, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Freeman, Sylvie, Dennis, Mike
Format: Article
Language:English
Subjects:
Oral Sessions
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue S3
container_start_page e252478c
container_title HemaSphere
container_volume 7
creator Russell, Nigel
Othman, Jad
Dillon, Richard
Potter, Nicola
Wilhelm‐Benartzi, Charlotte
Knapper, Steven
Batten, Leona
Canham, Joanna
Hinson, Emily Laura
Malthe Overgaard, Ulrik
Gilkes, Amanda
Mehta, Priyanka
Kottaridis, Panagiotis
Cavenagh, Jamie
Hemmaway, Claire
Arnold, Claire
Freeman, Sylvie
Dennis, Mike
description
doi_str_mv 10.1097/01.HS9.0000967448.25247.8c
format article
fullrecord <record><control><sourceid>wiley_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_95e71071f9cb4006add57d6991102ab4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_95e71071f9cb4006add57d6991102ab4</doaj_id><sourcerecordid>HEM3BF06209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2859-126e3447ce91df7bd25b4aa8826e119eb098835274d16c45fcb22f7b5dd21e0e3</originalsourceid><addsrcrecordid>eNqVks1u1DAUhSMEElXpO1isQGIGX8eJ426QJ_9SPBklziB1Y-XHKVNNO1WmgLrjEXgeHocnwTODgC7x4vr6-pzPXhzHeQ14Dpiz9xjmWc3n2C7uM0qDOfEIZfOgf-acEY-RGScUnv_Tv3Qu9vsbqwfOuU_YmfOjBpdeoqQQ6c9v3_NIoLCUi3wZR-hjrjKUxlI1V40UC1RelamQeZgv0Zu0fIuqOGpCq5NVhIp4HRc1EssI5XJVlWs7t6USRYHqplrna1Ega1yuJMhGISEPxyhexbYsFSoT-wXlHgEHXq2Eaup39o26KVSNkqqUSGXxwQgcqSoXxSvnxdhu9-bi937uNEmswmxWlGkeimLWk8DjMyC-cSllveEwjKwbiNfRtg0COwfgpsM8CFyPMDqA31Nv7DtCrM4bBgIGG_fcyU_cYdfe6Ptpc9tOj3rXbvRxsJuudTs9bPqt0dwzDDCDkfcdxdhvh8Fjg885ACZtRy3rw4l1_7m7NUNv7h6mdvsE-vTmbvNJX---aMCUBJR7lnB5IvTTbr-fzPjHDFgfYqExaBsL_TcW-hgLHfTWHJ7MXzdb8_gfTp3F0l0k2CeYu78Az1ixjg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL</title><source>PubMed Central (Open access)</source><source>Wiley-Blackwell Titles (Open access)</source><creator>Russell, Nigel ; Othman, Jad ; Dillon, Richard ; Potter, Nicola ; Wilhelm‐Benartzi, Charlotte ; Knapper, Steven ; Batten, Leona ; Canham, Joanna ; Hinson, Emily Laura ; Malthe Overgaard, Ulrik ; Gilkes, Amanda ; Mehta, Priyanka ; Kottaridis, Panagiotis ; Cavenagh, Jamie ; Hemmaway, Claire ; Arnold, Claire ; Freeman, Sylvie ; Dennis, Mike</creator><creatorcontrib>Russell, Nigel ; Othman, Jad ; Dillon, Richard ; Potter, Nicola ; Wilhelm‐Benartzi, Charlotte ; Knapper, Steven ; Batten, Leona ; Canham, Joanna ; Hinson, Emily Laura ; Malthe Overgaard, Ulrik ; Gilkes, Amanda ; Mehta, Priyanka ; Kottaridis, Panagiotis ; Cavenagh, Jamie ; Hemmaway, Claire ; Arnold, Claire ; Freeman, Sylvie ; Dennis, Mike</creatorcontrib><identifier>ISSN: 2572-9241</identifier><identifier>EISSN: 2572-9241</identifier><identifier>DOI: 10.1097/01.HS9.0000967448.25247.8c</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins</publisher><subject>Oral Sessions</subject><ispartof>HemaSphere, 2023-08, Vol.7 (S3), p.e252478c-n/a</ispartof><rights>Copyright © 2023 The Author(s).</rights><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428495/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428495/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11561,27923,27924,46051,46475,53790,53792</link.rule.ids></links><search><creatorcontrib>Russell, Nigel</creatorcontrib><creatorcontrib>Othman, Jad</creatorcontrib><creatorcontrib>Dillon, Richard</creatorcontrib><creatorcontrib>Potter, Nicola</creatorcontrib><creatorcontrib>Wilhelm‐Benartzi, Charlotte</creatorcontrib><creatorcontrib>Knapper, Steven</creatorcontrib><creatorcontrib>Batten, Leona</creatorcontrib><creatorcontrib>Canham, Joanna</creatorcontrib><creatorcontrib>Hinson, Emily Laura</creatorcontrib><creatorcontrib>Malthe Overgaard, Ulrik</creatorcontrib><creatorcontrib>Gilkes, Amanda</creatorcontrib><creatorcontrib>Mehta, Priyanka</creatorcontrib><creatorcontrib>Kottaridis, Panagiotis</creatorcontrib><creatorcontrib>Cavenagh, Jamie</creatorcontrib><creatorcontrib>Hemmaway, Claire</creatorcontrib><creatorcontrib>Arnold, Claire</creatorcontrib><creatorcontrib>Freeman, Sylvie</creatorcontrib><creatorcontrib>Dennis, Mike</creatorcontrib><title>S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL</title><title>HemaSphere</title><subject>Oral Sessions</subject><issn>2572-9241</issn><issn>2572-9241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqVks1u1DAUhSMEElXpO1isQGIGX8eJ426QJ_9SPBklziB1Y-XHKVNNO1WmgLrjEXgeHocnwTODgC7x4vr6-pzPXhzHeQ14Dpiz9xjmWc3n2C7uM0qDOfEIZfOgf-acEY-RGScUnv_Tv3Qu9vsbqwfOuU_YmfOjBpdeoqQQ6c9v3_NIoLCUi3wZR-hjrjKUxlI1V40UC1RelamQeZgv0Zu0fIuqOGpCq5NVhIp4HRc1EssI5XJVlWs7t6USRYHqplrna1Ega1yuJMhGISEPxyhexbYsFSoT-wXlHgEHXq2Eaup39o26KVSNkqqUSGXxwQgcqSoXxSvnxdhu9-bi937uNEmswmxWlGkeimLWk8DjMyC-cSllveEwjKwbiNfRtg0COwfgpsM8CFyPMDqA31Nv7DtCrM4bBgIGG_fcyU_cYdfe6Ptpc9tOj3rXbvRxsJuudTs9bPqt0dwzDDCDkfcdxdhvh8Fjg885ACZtRy3rw4l1_7m7NUNv7h6mdvsE-vTmbvNJX---aMCUBJR7lnB5IvTTbr-fzPjHDFgfYqExaBsL_TcW-hgLHfTWHJ7MXzdb8_gfTp3F0l0k2CeYu78Az1ixjg</recordid><startdate>20230808</startdate><enddate>20230808</enddate><creator>Russell, Nigel</creator><creator>Othman, Jad</creator><creator>Dillon, Richard</creator><creator>Potter, Nicola</creator><creator>Wilhelm‐Benartzi, Charlotte</creator><creator>Knapper, Steven</creator><creator>Batten, Leona</creator><creator>Canham, Joanna</creator><creator>Hinson, Emily Laura</creator><creator>Malthe Overgaard, Ulrik</creator><creator>Gilkes, Amanda</creator><creator>Mehta, Priyanka</creator><creator>Kottaridis, Panagiotis</creator><creator>Cavenagh, Jamie</creator><creator>Hemmaway, Claire</creator><creator>Arnold, Claire</creator><creator>Freeman, Sylvie</creator><creator>Dennis, Mike</creator><general>Lippincott Williams &amp; Wilkins</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230808</creationdate><title>S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL</title><author>Russell, Nigel ; Othman, Jad ; Dillon, Richard ; Potter, Nicola ; Wilhelm‐Benartzi, Charlotte ; Knapper, Steven ; Batten, Leona ; Canham, Joanna ; Hinson, Emily Laura ; Malthe Overgaard, Ulrik ; Gilkes, Amanda ; Mehta, Priyanka ; Kottaridis, Panagiotis ; Cavenagh, Jamie ; Hemmaway, Claire ; Arnold, Claire ; Freeman, Sylvie ; Dennis, Mike</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2859-126e3447ce91df7bd25b4aa8826e119eb098835274d16c45fcb22f7b5dd21e0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Oral Sessions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Russell, Nigel</creatorcontrib><creatorcontrib>Othman, Jad</creatorcontrib><creatorcontrib>Dillon, Richard</creatorcontrib><creatorcontrib>Potter, Nicola</creatorcontrib><creatorcontrib>Wilhelm‐Benartzi, Charlotte</creatorcontrib><creatorcontrib>Knapper, Steven</creatorcontrib><creatorcontrib>Batten, Leona</creatorcontrib><creatorcontrib>Canham, Joanna</creatorcontrib><creatorcontrib>Hinson, Emily Laura</creatorcontrib><creatorcontrib>Malthe Overgaard, Ulrik</creatorcontrib><creatorcontrib>Gilkes, Amanda</creatorcontrib><creatorcontrib>Mehta, Priyanka</creatorcontrib><creatorcontrib>Kottaridis, Panagiotis</creatorcontrib><creatorcontrib>Cavenagh, Jamie</creatorcontrib><creatorcontrib>Hemmaway, Claire</creatorcontrib><creatorcontrib>Arnold, Claire</creatorcontrib><creatorcontrib>Freeman, Sylvie</creatorcontrib><creatorcontrib>Dennis, Mike</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>Wiley Online Library Free Content</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>HemaSphere</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Russell, Nigel</au><au>Othman, Jad</au><au>Dillon, Richard</au><au>Potter, Nicola</au><au>Wilhelm‐Benartzi, Charlotte</au><au>Knapper, Steven</au><au>Batten, Leona</au><au>Canham, Joanna</au><au>Hinson, Emily Laura</au><au>Malthe Overgaard, Ulrik</au><au>Gilkes, Amanda</au><au>Mehta, Priyanka</au><au>Kottaridis, Panagiotis</au><au>Cavenagh, Jamie</au><au>Hemmaway, Claire</au><au>Arnold, Claire</au><au>Freeman, Sylvie</au><au>Dennis, Mike</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL</atitle><jtitle>HemaSphere</jtitle><date>2023-08-08</date><risdate>2023</risdate><volume>7</volume><issue>S3</issue><spage>e252478c</spage><epage>n/a</epage><pages>e252478c-n/a</pages><issn>2572-9241</issn><eissn>2572-9241</eissn><cop>Philadelphia, PA</cop><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1097/01.HS9.0000967448.25247.8c</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2572-9241
ispartof HemaSphere, 2023-08, Vol.7 (S3), p.e252478c-n/a
issn 2572-9241
2572-9241
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_95e71071f9cb4006add57d6991102ab4
source PubMed Central (Open access); Wiley-Blackwell Titles (Open access)
subjects Oral Sessions
title S134: FLAG‐IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A13%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S134:%20FLAG%E2%80%90IDA%20COMBINED%20WITH%20GEMTUZUMAB%20OZOGAMICIN%20(GO)%20REDUCED%20MRD%20LEVELS%20AND%20IMPROVED%20OVERALL%20SURVIVAL%20IN%20NPM1MUT%20AML%20INDEPENDENT%20OF%20FLT3%20AND%20MRD%20STATUS,%20RESULTS%20FROM%20THE%20AML19%20TRIAL&rft.jtitle=HemaSphere&rft.au=Russell,%20Nigel&rft.date=2023-08-08&rft.volume=7&rft.issue=S3&rft.spage=e252478c&rft.epage=n/a&rft.pages=e252478c-n/a&rft.issn=2572-9241&rft.eissn=2572-9241&rft_id=info:doi/10.1097/01.HS9.0000967448.25247.8c&rft_dat=%3Cwiley_doaj_%3EHEM3BF06209%3C/wiley_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2859-126e3447ce91df7bd25b4aa8826e119eb098835274d16c45fcb22f7b5dd21e0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true